4.2 Article

Impact of Disease-Modifying Therapies on the Survival of Patients with Multiple Sclerosis in Taiwan, 1997-2008

Related references

Note: Only part of the references are listed.
Article Neurosciences

Disease Modifying Drugs in Multiple Sclerosis: Mechanisms of Action and New Drugs in the Horizon

Monica Marta et al.

CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS (2012)

Article Public, Environmental & Occupational Health

A 20-Year Incidence Trend (1989-2008) and Point Prevalence (March 20, 2009) of Multiple Sclerosis in Tehran, Iran: A Population-Based Study

Seyedeh-Robab Elhami et al.

NEUROEPIDEMIOLOGY (2011)

Editorial Material Public, Environmental & Occupational Health

Are the Prevalence and Incidence of Multiple Sclerosis Changing?

Julian Benito-Leon

NEUROEPIDEMIOLOGY (2011)

Article Clinical Neurology

Multiple sclerosis survival: a population-based study in Sicily

P. Ragonese et al.

EUROPEAN JOURNAL OF NEUROLOGY (2010)

Review Psychiatry

Epidemiology of multiple sclerosis in Europe: A Review

Ephrosyni Koutsouraki et al.

INTERNATIONAL REVIEW OF PSYCHIATRY (2010)

Article Clinical Neurology

Increasing prevalence and incidence of multiple sclerosis in South East Wales

C. Hirst et al.

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2009)

Article Public, Environmental & Occupational Health

Population-Based Epidemiological Study of Neurological Diseases in Taiwan: I. Creutzfeldt-Jakob Disease and Multiple Sclerosis

Chien-Hsu Lai et al.

NEUROEPIDEMIOLOGY (2009)

Article Clinical Neurology

Survival and cause of death in multiple sclerosis: results from a 50-year follow-up in Western Norway

N. Grytten Torkildsen et al.

MULTIPLE SCLEROSIS JOURNAL (2008)

Article Clinical Neurology

A population-based survey of multiple sclerosis in Shanghai, China

Q. Cheng et al.

NEUROLOGY (2007)